Video Shorts
0:57
Transforming Care from Discovery to Delivery
8 months ago
by
Chris Mazzolini
0:41
MJH Buys BPD: Expanding Reach to Clinicians, Patients
8 months ago
by
Chris Mazzolini
0:48
The Problems DTC Can Address
8 months ago
by
Mike Hollan(+1 more)
0:52
What Makes TrumpRx Unique
8 months ago
by
Mike Hollan(+1 more)
0:44
Looming DSCSA Enforcement
8 months ago
by
Nicholas Jacobus(+1 more)
0:53
Transitioning from COO to CEO
8 months ago
by
Mike Hollan(+1 more)
0:59
Obesity Medication's Unique Marketing Environment
8 months ago
by
Mike Hollan
1:06
AI at FDA
8 months ago
by
Mike Hollan
0:59
Preparing for Tariffs
8 months ago
by
Mike Hollan
0:34
Federated Data Networks
8 months ago
by
Mike Hollan
0:47
The Breakthrough of Multiomics
8 months ago
by
Mike Hollan
1:01
Regulatory Uncertainty
9 months ago
by
Mike Hollan
Advertisement
Advertisement
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
The Industry's Interest in Vaccine Platforms
5